首页 > 最新文献

Journal of the Chinese Medical Association : JCMA最新文献

英文 中文
Evolving treatment and survival in hypopharyngeal cancer: A single-center study. 下咽癌的发展治疗和生存:一项单中心研究。
IF 2.4 Pub Date : 2025-10-01 Epub Date: 2025-08-07 DOI: 10.1097/JCMA.0000000000001279
Chia-Fan Chang, Pen-Yuan Chu

Background: Patients with hypopharyngeal squamous cell carcinoma (HPSCC) often present with advanced disease, resulting in poor prognoses. Traditional treatment involves radical surgery, which affects the quality of life considerably. At present, treatment is shifting away from primary surgical therapy. However, the long-term adverse effect is notable. This study examined the treatment outcomes of patients with HPSCC at a single medical center to assess the effects of evolving treatment modalities on survival and laryngeal preservation.

Methods: This retrospective study analyzed patients with HPSCC treated from 2004 to 2012. To assess the effects of changes in treatment modalities, the study period was divided into three blocks: 2004-2006, 2007-2009, and 2010-2012. Tumor recurrence, functional laryngeal outcomes, and survival rates were assessed across the three periods.

Results: A total of 167 patients with HPSCC (161 males and seven females; median age: 57 years) were analyzed. The proportion of patients undergoing surgery, specifically transoral laser microsurgery (TLM), increased over time. The laryngeal preservation rates increased from 14% to 41%, and the tumor recurrence rates reduced from 48% to 31% over the study period. Surgery-based treatment was associated with survival rates comparable to those of chemoradiotherapy, with 5-year overall survival and disease-specific survival rates increasing over time from 32% to 55% and from 37% to 73%, respectively.

Conclusion: Advancements in surgical techniques, precise radiotherapy, chemotherapy regimens, and refined treatment protocols have significantly enhanced survival outcomes and laryngeal preservation rates for patients with HPSCC over time. TLM has emerged as an effective conservation surgery in patients with early-stage and select cases of advanced HPSCC, offering the benefit of preserving laryngeal function.

背景:下咽鳞状细胞癌(HPSCC)患者通常表现为疾病晚期,导致预后不良。传统的治疗包括根治性手术,这在很大程度上影响了生活质量。目前,治疗正在从最初的手术治疗转移。然而,长期的不良影响是显著的。本研究在单一医疗中心检查了HPSCC患者的治疗结果,以评估不断发展的治疗方式对生存和喉保存的影响。方法:回顾性分析2004 ~ 2012年接受HPSCC治疗的患者。为了评估治疗方式改变的效果,研究期分为三个阶段:2004-2006年、2007-2009年和2010-2012年。肿瘤复发率,喉功能预后和生存率在三个时期进行评估。结果:167例HPSCC患者(男性161例,女性7例;中位年龄:57岁)。接受手术的患者比例,特别是经口激光显微手术(TLM),随着时间的推移而增加。在研究期间,喉部保存率从14%上升到41%,肿瘤复发率从48%下降到31%。手术治疗的生存率与放化疗相当,5年总生存率和疾病特异性生存率分别从32%增加到55%和从37%增加到73%。结论:随着时间的推移,手术技术的进步、精确的放疗、化疗方案和完善的治疗方案显著提高了HPSCC患者的生存结局和喉保存率。TLM已成为早期和晚期HPSCC患者的有效保护手术,提供保留喉功能的好处。
{"title":"Evolving treatment and survival in hypopharyngeal cancer: A single-center study.","authors":"Chia-Fan Chang, Pen-Yuan Chu","doi":"10.1097/JCMA.0000000000001279","DOIUrl":"10.1097/JCMA.0000000000001279","url":null,"abstract":"<p><strong>Background: </strong>Patients with hypopharyngeal squamous cell carcinoma (HPSCC) often present with advanced disease, resulting in poor prognoses. Traditional treatment involves radical surgery, which affects the quality of life considerably. At present, treatment is shifting away from primary surgical therapy. However, the long-term adverse effect is notable. This study examined the treatment outcomes of patients with HPSCC at a single medical center to assess the effects of evolving treatment modalities on survival and laryngeal preservation.</p><p><strong>Methods: </strong>This retrospective study analyzed patients with HPSCC treated from 2004 to 2012. To assess the effects of changes in treatment modalities, the study period was divided into three blocks: 2004-2006, 2007-2009, and 2010-2012. Tumor recurrence, functional laryngeal outcomes, and survival rates were assessed across the three periods.</p><p><strong>Results: </strong>A total of 167 patients with HPSCC (161 males and seven females; median age: 57 years) were analyzed. The proportion of patients undergoing surgery, specifically transoral laser microsurgery (TLM), increased over time. The laryngeal preservation rates increased from 14% to 41%, and the tumor recurrence rates reduced from 48% to 31% over the study period. Surgery-based treatment was associated with survival rates comparable to those of chemoradiotherapy, with 5-year overall survival and disease-specific survival rates increasing over time from 32% to 55% and from 37% to 73%, respectively.</p><p><strong>Conclusion: </strong>Advancements in surgical techniques, precise radiotherapy, chemotherapy regimens, and refined treatment protocols have significantly enhanced survival outcomes and laryngeal preservation rates for patients with HPSCC over time. TLM has emerged as an effective conservation surgery in patients with early-stage and select cases of advanced HPSCC, offering the benefit of preserving laryngeal function.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"760-766"},"PeriodicalIF":2.4,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12718694/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144796572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phenylalanyl-tRNA synthetase subunit beta downregulation by spi1 proto-oncogene modulates lung adenocarcinoma progression and immune microenvironment via mammalian target of rapamycin pathway. SPI1下调FARSB通过mTOR途径调控肺腺癌进展和免疫微环境。
IF 2.4 Pub Date : 2025-10-01 Epub Date: 2025-09-03 DOI: 10.1097/JCMA.0000000000001286
Yiting Wang, Yifan Zhou, Shangwei Chen, Jianwei Huang, Chen Zhang, Shuping Huang, Yujia Pan, Xiaoyan Huang, Junqi Qin, Shenghua Lin

Background: Phenylalanyl-tRNA synthetase subunit beta (FARSB) is implicated in the progression of multiple cancers and represents a potential therapeutic target. However, its role in lung adenocarcinoma (LUAD) progression and the immune microenvironment remains poorly understood, warranting further investigation into its regulatory mechanisms.

Methods: We conducted bioinformatics analyses to investigate the expression levels of FARSB in LUAD, identify enriched pathways, and assess its correlation with patient prognosis and CD8 + T cell infiltration. Bioinformatics analysis was also used to explore the transcriptional repression of FARSB by spi1 proto-oncogene (SPI1) and to validate the targeting relationship between SPI1 and FARSB. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was utilized to measure the mRNA expression of FARSB and SPI1, while western blot was used to detect the expression of FARSB, SPI1, programmed death-ligand 1 (PD-L1), and related signaling pathway proteins. Functional assays were performed, including CCK-8 assay for cell viability, EdU incorporation for cell proliferation, and flow cytometry for apoptosis analysis. Carboxyfluorescein succinimidyl ester (CFSE) staining was used to analyze CD8 + T cell proliferation, and flow cytometry was used to assess the expression of cytokines interferon-gamma (IFN-γ), Granzyme B (GZMB), and tumor necrosis factor-alpha (TNF-α).

Results: FARSB expression was significantly upregulated in LUAD tissues and cells, and it inhibited CD8 + T cell infiltration. Mechanistically, FARSB activated the mammalian target of rapamycin (mTOR) signaling pathway, enhancing LUAD cell viability, proliferation, and anti-apoptotic capabilities, consequently promoting CD8 + T cell exhaustion. The transcription factor SPI1 repressed FARSB expression, thus inhibiting LUAD progression and promoting CD8 + T cell anti-tumor immunity.

Conclusion: SPI1 downregulated FARSB expression through transcriptional repression, thereby blocking the mTOR signaling pathway and suppressing LUAD progression and promoting CD8 + T cell anti-tumor immunity.

背景:苯丙酰trna合成酶亚单位β (FARSB)与多种癌症的进展有关,是一种潜在的治疗靶点。然而,其在肺腺癌(LUAD)进展和免疫微环境中的作用仍然知之甚少,需要进一步研究其调节机制。方法:通过生物信息学分析,研究FARSB在LUAD中的表达水平,确定其富集途径,并评估其与患者预后和CD8+ T细胞浸润的相关性。利用生物信息学分析探讨了SPI1对FARSB的转录抑制作用,验证了SPI1与FARSB的靶向关系。采用qRT-PCR检测FARSB、SPI1 mRNA表达,Western blot检测FARSB、SPI1、PD-L1及相关信号通路蛋白表达。进行功能分析,包括CCK-8法检测细胞活力,EdU掺入法检测细胞增殖,流式细胞术检测细胞凋亡。CFSE染色检测CD8+ T细胞增殖,流式细胞术检测细胞因子IFN-γ、GZMB、TNF-α的表达。结果:在LUAD组织和细胞中,FARSB表达显著上调,抑制CD8+ T细胞浸润。在机制上,FARSB激活mTOR信号通路,增强LUAD细胞活力、增殖和抗凋亡能力,从而促进CD8+ T细胞衰竭。转录因子SPI1抑制FARSB表达,从而抑制LUAD进展,促进CD8+T细胞抗肿瘤免疫。结论:SPI1通过转录抑制下调FARSB表达,从而阻断mTOR信号通路,抑制LUAD进展,促进CD8+T细胞抗肿瘤免疫。
{"title":"Phenylalanyl-tRNA synthetase subunit beta downregulation by spi1 proto-oncogene modulates lung adenocarcinoma progression and immune microenvironment via mammalian target of rapamycin pathway.","authors":"Yiting Wang, Yifan Zhou, Shangwei Chen, Jianwei Huang, Chen Zhang, Shuping Huang, Yujia Pan, Xiaoyan Huang, Junqi Qin, Shenghua Lin","doi":"10.1097/JCMA.0000000000001286","DOIUrl":"10.1097/JCMA.0000000000001286","url":null,"abstract":"<p><strong>Background: </strong>Phenylalanyl-tRNA synthetase subunit beta (FARSB) is implicated in the progression of multiple cancers and represents a potential therapeutic target. However, its role in lung adenocarcinoma (LUAD) progression and the immune microenvironment remains poorly understood, warranting further investigation into its regulatory mechanisms.</p><p><strong>Methods: </strong>We conducted bioinformatics analyses to investigate the expression levels of FARSB in LUAD, identify enriched pathways, and assess its correlation with patient prognosis and CD8 + T cell infiltration. Bioinformatics analysis was also used to explore the transcriptional repression of FARSB by spi1 proto-oncogene (SPI1) and to validate the targeting relationship between SPI1 and FARSB. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was utilized to measure the mRNA expression of FARSB and SPI1, while western blot was used to detect the expression of FARSB, SPI1, programmed death-ligand 1 (PD-L1), and related signaling pathway proteins. Functional assays were performed, including CCK-8 assay for cell viability, EdU incorporation for cell proliferation, and flow cytometry for apoptosis analysis. Carboxyfluorescein succinimidyl ester (CFSE) staining was used to analyze CD8 + T cell proliferation, and flow cytometry was used to assess the expression of cytokines interferon-gamma (IFN-γ), Granzyme B (GZMB), and tumor necrosis factor-alpha (TNF-α).</p><p><strong>Results: </strong>FARSB expression was significantly upregulated in LUAD tissues and cells, and it inhibited CD8 + T cell infiltration. Mechanistically, FARSB activated the mammalian target of rapamycin (mTOR) signaling pathway, enhancing LUAD cell viability, proliferation, and anti-apoptotic capabilities, consequently promoting CD8 + T cell exhaustion. The transcription factor SPI1 repressed FARSB expression, thus inhibiting LUAD progression and promoting CD8 + T cell anti-tumor immunity.</p><p><strong>Conclusion: </strong>SPI1 downregulated FARSB expression through transcriptional repression, thereby blocking the mTOR signaling pathway and suppressing LUAD progression and promoting CD8 + T cell anti-tumor immunity.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"790-799"},"PeriodicalIF":2.4,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12718725/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144984157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Macular vessel density is associated with cognitive function in preclinical p.R544C NOTCH3 mutation carriers: Erratum. 临床前p.R544C NOTCH3突变携带者的黄斑血管密度与认知功能相关:勘误
IF 2.4 Pub Date : 2025-10-01 Epub Date: 2025-10-20 DOI: 10.1097/JCMA.0000000000001285
Chien-Chih Chou, Chiao-Ying Liang, Chen-Yu Lin, I-Jong Wanga, Chia-Jen Chang, Jun-Peng Chen, Hsin Tung, Hung-Chieh Chen, Hsian-Min Chen, Yi-Ming Chen, Wei-Ju Lee
{"title":"Macular vessel density is associated with cognitive function in preclinical p.R544C NOTCH3 mutation carriers: Erratum.","authors":"Chien-Chih Chou, Chiao-Ying Liang, Chen-Yu Lin, I-Jong Wanga, Chia-Jen Chang, Jun-Peng Chen, Hsin Tung, Hung-Chieh Chen, Hsian-Min Chen, Yi-Ming Chen, Wei-Ju Lee","doi":"10.1097/JCMA.0000000000001285","DOIUrl":"10.1097/JCMA.0000000000001285","url":null,"abstract":"","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":"88 10","pages":"807"},"PeriodicalIF":2.4,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12718702/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145310562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimizing care for chronic kidney disease: Considerations from A to Z. 优化慢性肾脏疾病的护理:从A到Z的考虑。
IF 2.4 Pub Date : 2025-10-01 Epub Date: 2025-08-12 DOI: 10.1097/JCMA.0000000000001280
Fan-Yu Chen, Wan-Chen Chang, Zih-Kai Kao, Ann Charis Tan, Szu-Yuan Li, Chih-Yu Yang, Hsuan Lin, Chih-Ching Lin

Chronic kidney disease (CKD) management requires a comprehensive and multidisciplinary approach to optimize clinical outcomes. This review systematically outlines essential components of CKD care from A to Z, offering evidence-based guidance to enhance patient management. Anemia treatment emphasizes iron supplementation, erythropoiesis-stimulating agents, and novel hypoxia-inducible factor prolyl hydroxylase inhibitors. Achieving optimal blood pressure control through renin-angiotensin system inhibitors and calcium channel blockers reduces cardiovascular risk and delays CKD progression. Cardiovascular risk management includes statins combined with ezetimibe or proprotein convertase subtilisin/kexin type 9 inhibitors, along with appropriate anticoagulation therapy for atrial fibrillation. Individualized glycemic control strategies prioritize sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists for their cardiovascular and renal protective effects. Vigilance in avoiding nephrotoxic agents, such as non-steroidal anti-inflammatory drugs, proton pump inhibitors, aminoglycosides, and contrast media, is essential for preventing renal injury. Rigorous management of electrolytes and acid-base disturbances, involving dietary sodium and potassium restrictions, phosphate binders, and bicarbonate supplementation, reduces CKD progression and related complications. Appropriate fluid management through dietary sodium and water restriction with individualized diuretic therapy prevents volume overload and associated cardiovascular complications. Nutritional interventions, particularly low-protein diets supplemented with ketoanalogues of amino acids, effectively delay CKD progression and control metabolic disturbances. Therapies addressing CKD-related mineral and bone disorders, including phosphate binders, vitamin D analogues, and calcimimetics, reduce the risk of vascular calcification. In addition, lipid-lowering therapies, anticoagulation therapy, optimal vascular access management for dialysis, and early detection of arrhythmias and thrombotic microangiopathy significantly enhance patient outcomes. Attention to quality of life issues, such as alleviating xerosis symptoms, promoting optimal body mass index through weight management strategies, and providing psychosocial support, further enhances patient-centered care. This comprehensive review highlights the crucial importance of a multidisciplinary approach in CKD management.

慢性肾脏疾病(CKD)的管理需要综合和多学科的方法来优化临床结果。这篇综述系统地概述了从A到Z的CKD护理的基本组成部分,为加强患者管理提供循证指导。贫血治疗强调补铁、促红细胞生成剂和新型缺氧诱导因子脯氨酸羟化酶抑制剂。通过肾素-血管紧张素系统抑制剂和钙通道阻滞剂实现最佳血压控制可降低心血管风险并延缓CKD进展。心血管风险管理包括他汀类药物联合依折替米或蛋白转化酶枯草杆菌素/kexin 9型抑制剂,以及房颤适当的抗凝治疗。个体化血糖控制策略优先考虑钠-葡萄糖共转运蛋白-2抑制剂和胰高血糖素样肽-1受体激动剂的心血管和肾脏保护作用。警惕避免使用肾毒性药物,如非甾体类抗炎药、质子泵抑制剂、氨基糖苷类和造影剂,对预防肾损伤至关重要。严格管理电解质和酸碱紊乱,包括饮食钠和钾限制、磷酸盐结合剂和碳酸氢盐补充,可减少CKD进展和相关并发症。适当的液体管理,通过饮食钠和水限制个体化利尿剂治疗,防止容量超载和相关的心血管并发症。营养干预,特别是补充氨基酸酮类类似物的低蛋白饮食,可以有效延缓CKD的进展并控制代谢紊乱。针对ckd相关矿物质和骨骼疾病的治疗,包括磷酸盐结合剂、维生素D类似物和钙化剂,可以降低血管钙化的风险。此外,降脂治疗、抗凝治疗、透析的最佳血管通路管理以及心律失常和血栓性微血管病的早期发现显著提高了患者的预后。对生活质量问题的关注,如减轻干燥症状,通过体重管理策略促进最佳体重指数,以及提供社会心理支持,进一步加强了以患者为中心的护理。这篇全面的综述强调了多学科方法在CKD管理中的重要性。
{"title":"Optimizing care for chronic kidney disease: Considerations from A to Z.","authors":"Fan-Yu Chen, Wan-Chen Chang, Zih-Kai Kao, Ann Charis Tan, Szu-Yuan Li, Chih-Yu Yang, Hsuan Lin, Chih-Ching Lin","doi":"10.1097/JCMA.0000000000001280","DOIUrl":"10.1097/JCMA.0000000000001280","url":null,"abstract":"<p><p>Chronic kidney disease (CKD) management requires a comprehensive and multidisciplinary approach to optimize clinical outcomes. This review systematically outlines essential components of CKD care from A to Z, offering evidence-based guidance to enhance patient management. Anemia treatment emphasizes iron supplementation, erythropoiesis-stimulating agents, and novel hypoxia-inducible factor prolyl hydroxylase inhibitors. Achieving optimal blood pressure control through renin-angiotensin system inhibitors and calcium channel blockers reduces cardiovascular risk and delays CKD progression. Cardiovascular risk management includes statins combined with ezetimibe or proprotein convertase subtilisin/kexin type 9 inhibitors, along with appropriate anticoagulation therapy for atrial fibrillation. Individualized glycemic control strategies prioritize sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists for their cardiovascular and renal protective effects. Vigilance in avoiding nephrotoxic agents, such as non-steroidal anti-inflammatory drugs, proton pump inhibitors, aminoglycosides, and contrast media, is essential for preventing renal injury. Rigorous management of electrolytes and acid-base disturbances, involving dietary sodium and potassium restrictions, phosphate binders, and bicarbonate supplementation, reduces CKD progression and related complications. Appropriate fluid management through dietary sodium and water restriction with individualized diuretic therapy prevents volume overload and associated cardiovascular complications. Nutritional interventions, particularly low-protein diets supplemented with ketoanalogues of amino acids, effectively delay CKD progression and control metabolic disturbances. Therapies addressing CKD-related mineral and bone disorders, including phosphate binders, vitamin D analogues, and calcimimetics, reduce the risk of vascular calcification. In addition, lipid-lowering therapies, anticoagulation therapy, optimal vascular access management for dialysis, and early detection of arrhythmias and thrombotic microangiopathy significantly enhance patient outcomes. Attention to quality of life issues, such as alleviating xerosis symptoms, promoting optimal body mass index through weight management strategies, and providing psychosocial support, further enhances patient-centered care. This comprehensive review highlights the crucial importance of a multidisciplinary approach in CKD management.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"738-746"},"PeriodicalIF":2.4,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12718738/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144823554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genomic insights for triple-negative breast cancer patients in Taiwan. 台湾三阴性乳癌患者的基因组分析。
IF 2.4 Pub Date : 2025-10-01 Epub Date: 2025-08-25 DOI: 10.1097/JCMA.0000000000001283
Peng-Hui Wang, Szu-Ting Yang, Hsiang-Tai Chao
{"title":"Genomic insights for triple-negative breast cancer patients in Taiwan.","authors":"Peng-Hui Wang, Szu-Ting Yang, Hsiang-Tai Chao","doi":"10.1097/JCMA.0000000000001283","DOIUrl":"10.1097/JCMA.0000000000001283","url":null,"abstract":"","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"735-737"},"PeriodicalIF":2.4,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12718677/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144984165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical features and surgical treatment of hemophilic pseudotumors: A single-center experience over a 20-year period. 血友病性假肿瘤的临床特征和手术治疗:单中心20年的经验。
IF 2.4 Pub Date : 2025-10-01 Epub Date: 2025-09-04 DOI: 10.1097/JCMA.0000000000001290
Cheng-Fong Chen, Liang-Tsai Hsiao, Jan-Wei Chiu, Shang-Wen Tsai, Chao-Ming Chen, Po-Kuei Wu, Wei-Ming Chen

Background: Hemophilic pseudotumor (HPT) is an uncommon but severe complication in patients with hemophilia (PWH). Given the rarity, case series were scarce and largely confined to case report in the literature. Consequently, the aim of this study is to present surgical results of HPT over a 20-year period from a single institute.

Methods: We retrospectively reviewed 11 HPT in 10 PWH who underwent surgical treatment in our institute between 1999 and 2020. Their clinical features, surgical management, outcomes, and complications were identified.

Results: There are 10 men PWH with 11 HPT who had undergone a total of 20 surgical procedures over a 20-year period. The mean age at surgery was 41.2 years with an average follow-up of 9.7 years. Nine patients had hemophilia A (five severe, three moderate, and one mild) and one patient had severe hemophilia B. Localization of the HPT was confined to soft tissue in two patients (9.1%), to intraosseous lesion in five patients (45.5%) and to subperiosteal location in the remaining four patients (36.4%). Three patients (27.2%) had complications, including one wound infection, one chronic osteomyelitis, and one recurrence. Postoperative complete resolution was achieved in nine HPT except one recurrence and one persistent chronic osteomyelitis; the former was stable after further excision, and the latter was resolved by amputation.

Conclusion: Surgical therapy for HTP is feasible and effective when covered with adequate factor replacement. Given the variety, careful case-to-case evaluation is important to take the appropriate surgical modality and avoid potential complication.

背景:血友病假肿瘤(HPT)是血友病(PWH)患者中一种罕见但严重的并发症。鉴于其罕见性,病例系列很少,并且在文献中主要局限于病例报告。因此,本研究的目的是介绍一个研究所20年来HPT的手术结果。方法回顾性分析1999年至2020年在我院接受手术治疗的10例PWH患者中的11例HPT。确定了他们的临床特征、手术处理、结局和并发症。结果:10例男性PWH伴11例HPT, 20年间共接受了20次手术。手术时平均年龄为41.2岁,平均随访时间为9.7年。9例患者为A型血友病(5例重度、3例中度和1例轻度),1例患者为重度b型血友病。HPT定位于软组织2例(9.1%),骨内病变5例(45.5%),骨膜下病变4例(36.4%)。3例患者(27.2%)出现并发症,包括1例伤口感染、1例慢性骨髓炎和1例复发。9例HPT术后完全痊愈,1例复发,1例持续慢性骨髓炎,前者经进一步切除后病情稳定,后经截肢痊愈。结论:手术治疗HTP是可行和有效的,只要有适当的因素替代。鉴于各种各样,仔细的个案评估对于采取合适的手术方式和避免潜在的并发症是很重要的。
{"title":"Clinical features and surgical treatment of hemophilic pseudotumors: A single-center experience over a 20-year period.","authors":"Cheng-Fong Chen, Liang-Tsai Hsiao, Jan-Wei Chiu, Shang-Wen Tsai, Chao-Ming Chen, Po-Kuei Wu, Wei-Ming Chen","doi":"10.1097/JCMA.0000000000001290","DOIUrl":"10.1097/JCMA.0000000000001290","url":null,"abstract":"<p><strong>Background: </strong>Hemophilic pseudotumor (HPT) is an uncommon but severe complication in patients with hemophilia (PWH). Given the rarity, case series were scarce and largely confined to case report in the literature. Consequently, the aim of this study is to present surgical results of HPT over a 20-year period from a single institute.</p><p><strong>Methods: </strong>We retrospectively reviewed 11 HPT in 10 PWH who underwent surgical treatment in our institute between 1999 and 2020. Their clinical features, surgical management, outcomes, and complications were identified.</p><p><strong>Results: </strong>There are 10 men PWH with 11 HPT who had undergone a total of 20 surgical procedures over a 20-year period. The mean age at surgery was 41.2 years with an average follow-up of 9.7 years. Nine patients had hemophilia A (five severe, three moderate, and one mild) and one patient had severe hemophilia B. Localization of the HPT was confined to soft tissue in two patients (9.1%), to intraosseous lesion in five patients (45.5%) and to subperiosteal location in the remaining four patients (36.4%). Three patients (27.2%) had complications, including one wound infection, one chronic osteomyelitis, and one recurrence. Postoperative complete resolution was achieved in nine HPT except one recurrence and one persistent chronic osteomyelitis; the former was stable after further excision, and the latter was resolved by amputation.</p><p><strong>Conclusion: </strong>Surgical therapy for HTP is feasible and effective when covered with adequate factor replacement. Given the variety, careful case-to-case evaluation is important to take the appropriate surgical modality and avoid potential complication.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"774-782"},"PeriodicalIF":2.4,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12718701/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145031554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence-assisted glaucoma detection on color fundus images: with comorbidity and cross-institutional analysis. 人工智能辅助青光眼彩色眼底图像检测:合并症和跨机构分析。
IF 2.4 Pub Date : 2025-10-01 Epub Date: 2025-09-04 DOI: 10.1097/JCMA.0000000000001289
Wei-Shiang Chen, Yu-Chieh Ko, Yen-Cheng Chen, Henry Horng-Shing Lu

Background: Glaucoma is a major cause of irreversible blindness, and early detection is essential to prevent vision loss. Color fundus photography is a simple, low-cost, and noninvasive eye screening method, but diagnosis through this method can be difficult in patients with additional retinal diseases. Although artificial intelligence (AI) can address this difficulty, its effectiveness may vary between hospitals. In this study, an AI glaucoma detection system was developed and tested for reliability across different populations and clinical settings.

Methods: A stepwise AI pipeline was designed that combined image enhancement, automated identification of the optic nerve area, and deep learning-based classification. The system was trained on 1696 images from Taipei Veterans General Hospital and tested on five cross-regional external datasets. The system was also evaluated on a separate internal set of 151 images representing comorbid eye diseases.

Results: The AI system achieved a balanced accuracy of at least 80% on all external datasets. For images with other eye diseases, it achieved an area under the curve of 0.93 and a balanced accuracy of 80.9%. Its performance remained consistent regardless of differences in patient ethnicity, camera types, and image quality.

Conclusion: The proposed AI system can detect glaucoma on standard color fundus photographs with high accuracy across clinical environments and in the presence of comorbid eye diseases. The system may be a practical and affordable tool for large-scale glaucoma screening, particularly in institutions with limited resources.

背景:青光眼是不可逆失明的主要原因,早期发现对预防视力丧失至关重要。彩色眼底摄影是一种简单、低成本、无创的眼部筛查方法,但在患有其他视网膜疾病的患者中,通过这种方法进行诊断可能很困难。尽管人工智能(AI)可以解决这一难题,但其有效性可能因医院而异。在本研究中,开发了一种人工智能青光眼检测系统,并对其在不同人群和临床环境中的可靠性进行了测试。方法:设计了一种结合图像增强、视神经区域自动识别和深度学习分类的逐步人工智能流水线。该系统在台北荣民总医院的1696张图像上进行了训练,并在5个跨区域的外部数据集上进行了测试。该系统还在代表共病眼病的151张单独的内部图像集上进行了评估。结果:AI系统在所有外部数据集上实现了至少80%的平衡精度。对于其他眼病的图像,曲线下面积为0.93,平衡精度为80.9%。无论患者种族、相机类型和图像质量如何,其表现都是一致的。结论:本文提出的人工智能系统可以在临床环境和存在合并症的眼部疾病的情况下,对标准彩色眼底照片进行青光眼检测,准确率较高。该系统可能是大规模青光眼筛查的实用和负担得起的工具,特别是在资源有限的机构中。
{"title":"Artificial intelligence-assisted glaucoma detection on color fundus images: with comorbidity and cross-institutional analysis.","authors":"Wei-Shiang Chen, Yu-Chieh Ko, Yen-Cheng Chen, Henry Horng-Shing Lu","doi":"10.1097/JCMA.0000000000001289","DOIUrl":"10.1097/JCMA.0000000000001289","url":null,"abstract":"<p><strong>Background: </strong>Glaucoma is a major cause of irreversible blindness, and early detection is essential to prevent vision loss. Color fundus photography is a simple, low-cost, and noninvasive eye screening method, but diagnosis through this method can be difficult in patients with additional retinal diseases. Although artificial intelligence (AI) can address this difficulty, its effectiveness may vary between hospitals. In this study, an AI glaucoma detection system was developed and tested for reliability across different populations and clinical settings.</p><p><strong>Methods: </strong>A stepwise AI pipeline was designed that combined image enhancement, automated identification of the optic nerve area, and deep learning-based classification. The system was trained on 1696 images from Taipei Veterans General Hospital and tested on five cross-regional external datasets. The system was also evaluated on a separate internal set of 151 images representing comorbid eye diseases.</p><p><strong>Results: </strong>The AI system achieved a balanced accuracy of at least 80% on all external datasets. For images with other eye diseases, it achieved an area under the curve of 0.93 and a balanced accuracy of 80.9%. Its performance remained consistent regardless of differences in patient ethnicity, camera types, and image quality.</p><p><strong>Conclusion: </strong>The proposed AI system can detect glaucoma on standard color fundus photographs with high accuracy across clinical environments and in the presence of comorbid eye diseases. The system may be a practical and affordable tool for large-scale glaucoma screening, particularly in institutions with limited resources.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":"88 10","pages":"747-759"},"PeriodicalIF":2.4,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12718736/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145310552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The trend of utilizing de-escalation of surgical extent for treating early-stage cervical cancer patients. 早期宫颈癌患者手术程度降低的趋势。
IF 2.4 Pub Date : 2025-09-01 Epub Date: 2025-07-22 DOI: 10.1097/JCMA.0000000000001272
Szu-Ting Yang, Peng-Hui Wang, Chia-Hao Liu
{"title":"The trend of utilizing de-escalation of surgical extent for treating early-stage cervical cancer patients.","authors":"Szu-Ting Yang, Peng-Hui Wang, Chia-Hao Liu","doi":"10.1097/JCMA.0000000000001272","DOIUrl":"10.1097/JCMA.0000000000001272","url":null,"abstract":"","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"657-659"},"PeriodicalIF":2.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12637161/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144692867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of ulnar fracture level on radial head dislocation: A Monteggia fracture study. 尺骨骨折水平对桡骨头脱位的影响:一项Monteggia骨折研究。
IF 2.4 Pub Date : 2025-09-01 Epub Date: 2025-07-30 DOI: 10.1097/JCMA.0000000000001276
Kuan-Yu Huang, Chun-Yu Chen, Kai-Cheng Lin

Background: Monteggia fracture is defined as a combination of a proximal ulnar fracture with radial head dislocation. Radial head dislocation may be misdiagnosed under an elbow radiograph, leading to further complications. This study aimed to compare the ulnar fracture pattern characteristics between Monteggia fracture and an isolated proximal ulnar fracture in terms of how close the fracture site is to the coronoid and what type of fracture pattern is more likely to result in radial head dislocation.

Methods: This single-center retrospective study, conducted from January 2014 to June 2022, included adult patients with proximal to midshaft ulnar fractures, excluding nonacute trauma, revision surgeries, and intra-articular fractures. All patients underwent anteroposterior (AP) and lateral elbow radiographs and forearm radiograph. Fracture patterns and injury mechanisms were recorded for analysis.

Results: We included 51 patients in this study. The mean age was 38.5 ± 16.1 years, and 70.1% were men (n = 36). Monteggia fractures were classified according to the Bado classification into type I (n = 5), type II (n = 7), type III (n = 8), and type IV (n = 0). Traffic accidents comprised 63% of the injuries (n = 32), and 45% were oblique type ulnar fractures (n = 23). Monteggia fracture and proximal ulnar fracture presented with mean distance from coronoid tip to fracture of 6.12 ± 2.32 cm and 9.00 ± 3.00 cm ( p < 0.01). As per the receiver operating characteristic curve (ROC), the distance from coronoid tip to fracture of 7.33 cm had the highest area under the curve (AUC) value (0.807). Angulations of Monteggia fracture and isolated ulnar fracture were 24.02° ± 12.10° and 10.77° ± 8.10° ( p < 0.01). However, there were no differences in the length of the fracture line between two groups.

Conclusion: The distance from coronoid tip to fracture within 7.3 cm is more likely to cause a Monteggia fracture than an isolated proximal ulnar fracture. Otherwise, a Monteggia fracture is prone to more severe angulation.

背景:Monteggia骨折被定义为尺近端骨折合并桡骨头脱位。桡骨头脱位可能在肘部x线下被误诊,导致进一步的并发症。本研究旨在比较Monteggia骨折与孤立性尺近端骨折的尺骨骨折类型特征,包括骨折部位离冠突的距离以及哪种类型的骨折类型更容易导致桡骨头脱位。方法:这项单中心回顾性研究于2014年1月至2022年6月进行,纳入成年尺近端至中尺骨折患者,不包括非急性创伤、翻修手术和关节内骨折。所有患者均行AP、侧肘x光片和前臂x光片。记录骨折类型和损伤机制以供分析。结果:我们纳入了51例患者。平均年龄38.5±16.1岁,男性占70.1% (n=36)。根据Bado分型将Monteggia骨折分为I型(n=5)、II型(n=7)、III型(n=8)和IV型(n=0)。其中交通事故占63% (n=32)。45%为斜尺型骨折(n=23)。Monteggia骨折和尺近端骨折表现为冠尖到骨折的平均距离分别为6.12±2.32 cm和9.00±3.00 cm。结论:冠尖到骨折的距离在7.3 cm以内的骨折比孤立的尺近端骨折更容易发生Monteggia骨折。否则,蒙特吉亚骨折容易产生更严重的成角。
{"title":"Impact of ulnar fracture level on radial head dislocation: A Monteggia fracture study.","authors":"Kuan-Yu Huang, Chun-Yu Chen, Kai-Cheng Lin","doi":"10.1097/JCMA.0000000000001276","DOIUrl":"10.1097/JCMA.0000000000001276","url":null,"abstract":"<p><strong>Background: </strong>Monteggia fracture is defined as a combination of a proximal ulnar fracture with radial head dislocation. Radial head dislocation may be misdiagnosed under an elbow radiograph, leading to further complications. This study aimed to compare the ulnar fracture pattern characteristics between Monteggia fracture and an isolated proximal ulnar fracture in terms of how close the fracture site is to the coronoid and what type of fracture pattern is more likely to result in radial head dislocation.</p><p><strong>Methods: </strong>This single-center retrospective study, conducted from January 2014 to June 2022, included adult patients with proximal to midshaft ulnar fractures, excluding nonacute trauma, revision surgeries, and intra-articular fractures. All patients underwent anteroposterior (AP) and lateral elbow radiographs and forearm radiograph. Fracture patterns and injury mechanisms were recorded for analysis.</p><p><strong>Results: </strong>We included 51 patients in this study. The mean age was 38.5 ± 16.1 years, and 70.1% were men (n = 36). Monteggia fractures were classified according to the Bado classification into type I (n = 5), type II (n = 7), type III (n = 8), and type IV (n = 0). Traffic accidents comprised 63% of the injuries (n = 32), and 45% were oblique type ulnar fractures (n = 23). Monteggia fracture and proximal ulnar fracture presented with mean distance from coronoid tip to fracture of 6.12 ± 2.32 cm and 9.00 ± 3.00 cm ( p < 0.01). As per the receiver operating characteristic curve (ROC), the distance from coronoid tip to fracture of 7.33 cm had the highest area under the curve (AUC) value (0.807). Angulations of Monteggia fracture and isolated ulnar fracture were 24.02° ± 12.10° and 10.77° ± 8.10° ( p < 0.01). However, there were no differences in the length of the fracture line between two groups.</p><p><strong>Conclusion: </strong>The distance from coronoid tip to fracture within 7.3 cm is more likely to cause a Monteggia fracture than an isolated proximal ulnar fracture. Otherwise, a Monteggia fracture is prone to more severe angulation.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"686-691"},"PeriodicalIF":2.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12637151/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144746663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bibliographic analysis of Taiwanese publications in the Web of Science Respiratory System Category from 1972 to 2023. 1972 ~ 2023年科学网呼吸系统分类台湾出版物的文献分析。
IF 2.4 Pub Date : 2025-09-01 Epub Date: 2025-07-30 DOI: 10.1097/JCMA.0000000000001275
Ying-Hsuan Hwang, Chih-Teng Chiang, Yuh-Min Chen, I-Hsuan Hwang, Chun-Feng Huang, Yu-Chun Chen, Shinn-Jang Hwang

Background: Academic publications are important for developing medical specialties. Respiratory system diseases are among the most common human diseases and have a significant impact on morbidity and mortality. This is particularly true regarding the impact of the new coronavirus, severe acute respiratory syndrome coronavirus 2. This study aimed to perform a bibliographic analysis of Taiwanese academic publications in the Web of Science (WoS) subject category of respiratory systems.

Methods: Publications in the WoS Respiratory System Category, including papers in Science Citation Index Expanded and Social Sciences Citation Index journals from 1972 to 2023, were retrieved and analyzed.

Results: Among 392 030 papers published worldwide in the WoS Respiratory System Category from 1972 to 2023, 3672 (0.94%) were published in Taiwan, ranking 21st in the world, with a total of 82 956 citations. Over these five decades, the annual number of Taiwanese publications and citations has increased over time. However, the mean impact factor of publications has shown a tendency to decrease since 1997. International collaboration with coauthors outside Taiwan was found in 780 papers (21.24% of the total publications), mainly from the United States, the People's Republic of China, the United Kingdom, France, and South Korea. Collaborative papers had a significantly higher mean impact factor (8.2 ± 0.3 vs 5.6 ± 0.1, p < 0.001) and citation counts per paper (44.2 ± 3.3 vs 25.2 ± 0.8, p < 0.001) than those of non-collaborative papers.

Conclusion: Taiwanese publications in the WoS Respiratory System Category have a trend of increasing number and citations since 1972. However, the mean impact factor of the published papers has decreased since 1997. This disproportionate trend is an observational finding that deserves further investigation.

背景:学术出版物对医学专业的发展至关重要。呼吸系统疾病是最常见的人类疾病之一,对发病率和死亡率有重大影响。对于新型冠状病毒——严重急性呼吸系统综合征冠状病毒2的影响尤其如此。摘要本研究旨在对台湾地区在科学网(Web of Science)发表的以呼吸系统为主题的学术论文进行文献分析。方法:检索1972 ~ 2023年WoS呼吸系统分类出版物,包括Science引文索引扩展版和Social Sciences引文索引期刊。结果:1972 - 2023年全球发表的WoS呼吸系统分类392030篇论文中,台湾发表3672篇(0.94%),排名世界第21位,总被引82956次。在过去的五十年里,台湾每年的出版物和引用数量都在不断增加。但是,自1997年以来,出版物的平均影响因子呈下降趋势。有780篇论文与台湾地区以外的人有国际合作,占总发表数的21.24%,主要来自美国、中华人民共和国、英国、法国和韩国。合作论文的平均影响因子(8.2±0.3比5.6±0.1,p< 0.001)和被引频次(44.2±3.3比25.2±0.8,p< 0.001)显著高于非合作论文。结论:自1972年以来,台湾地区WoS呼吸系统类出版物的数量和引用数均有上升趋势。但自1997年以来,已发表论文的平均影响因子有所下降。这种不成比例的趋势是一个值得进一步研究的观察发现。
{"title":"Bibliographic analysis of Taiwanese publications in the Web of Science Respiratory System Category from 1972 to 2023.","authors":"Ying-Hsuan Hwang, Chih-Teng Chiang, Yuh-Min Chen, I-Hsuan Hwang, Chun-Feng Huang, Yu-Chun Chen, Shinn-Jang Hwang","doi":"10.1097/JCMA.0000000000001275","DOIUrl":"10.1097/JCMA.0000000000001275","url":null,"abstract":"<p><strong>Background: </strong>Academic publications are important for developing medical specialties. Respiratory system diseases are among the most common human diseases and have a significant impact on morbidity and mortality. This is particularly true regarding the impact of the new coronavirus, severe acute respiratory syndrome coronavirus 2. This study aimed to perform a bibliographic analysis of Taiwanese academic publications in the Web of Science (WoS) subject category of respiratory systems.</p><p><strong>Methods: </strong>Publications in the WoS Respiratory System Category, including papers in Science Citation Index Expanded and Social Sciences Citation Index journals from 1972 to 2023, were retrieved and analyzed.</p><p><strong>Results: </strong>Among 392 030 papers published worldwide in the WoS Respiratory System Category from 1972 to 2023, 3672 (0.94%) were published in Taiwan, ranking 21st in the world, with a total of 82 956 citations. Over these five decades, the annual number of Taiwanese publications and citations has increased over time. However, the mean impact factor of publications has shown a tendency to decrease since 1997. International collaboration with coauthors outside Taiwan was found in 780 papers (21.24% of the total publications), mainly from the United States, the People's Republic of China, the United Kingdom, France, and South Korea. Collaborative papers had a significantly higher mean impact factor (8.2 ± 0.3 vs 5.6 ± 0.1, p < 0.001) and citation counts per paper (44.2 ± 3.3 vs 25.2 ± 0.8, p < 0.001) than those of non-collaborative papers.</p><p><strong>Conclusion: </strong>Taiwanese publications in the WoS Respiratory System Category have a trend of increasing number and citations since 1972. However, the mean impact factor of the published papers has decreased since 1997. This disproportionate trend is an observational finding that deserves further investigation.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"709-716"},"PeriodicalIF":2.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12637120/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144746662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the Chinese Medical Association : JCMA
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1